Alphanox to Acquire Additional Shares of U.S. Subsidiary for 5.6 Billion KRW
Alphanox announced on the 19th that it will acquire an additional 4 million shares of its U.S. implant sales subsidiary (Solco Biomedical) for approximately 5.6 billion KRW.
After the acquisition, Alphanox's ownership stake will become 100%. The scheduled date of share acquisition is the 23rd.
Hot Picks Today
![South Korea's Hopes for Round of 32 Diminish... Sweden Becomes First Third-Place Team to Advance After Draw with Japan [2026 World Cup]](https://cwcontent.asiae.co.kr/asiaresize/93/2026062610054924490_1782435949.jpg)
South Korea's Hopes for Round of 32 Diminish... Sweden Becomes First Third-Place Team to Advance After Draw with Japan [2026 World Cup]
- After Two Days of Gains, Another 'Black Friday'... KOSPI Plunges Over 6% as Sell-Sidecar Is Triggered
- "OpenAI Considering Postponing IPO to 2027"
- "Who Would Leave?"... SK hynix's Voluntary Turnover Rate at Just 0.5% with Starting Salary of 4.5 Million Won for New Hires
- "‘Hong Myungbo Banned from Entry’ Posted on Convenience Store Door... Headquarters Investigating Store Location"
The company stated that the purpose of this acquisition is to strengthen business competitiveness in the U.S. market and to improve its financial structure.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
!["Women Were Excluded from Promotion"... A Bombshell Aide Under a Bombshell President [World Photo]](https://cwcontent.asiae.co.kr/asiaresize/307/2026062512310523344_1782358266.png)
